IDRA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: IDRA Shares Outstanding History and IDRA YTD Return |
IDRA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: IDRA Shares Outstanding History and IDRA YTD Return |
IDRA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-11.17% CAGR Mouse over chart for data details
|
IDRA Stock Price Chart |
About Aceragen Inc |
Idera Pharmaceuticals is a biopharmaceutical company focused on the clinical development, and the commercialization, of drug candidates for rare disease indications characterized by patient populations with unmet medical needs. Co.'s focus is to identify and acquire rights to development and commercial stage rare disease programs through new business development opportunities, including additional alternatives. Co. is evaluating intratumoral tilsotolimod in combination with nivolumab, an anti-Progressive Disease 1 antibody marketed as Opdivo® by Bristol Myers Squibb Company, and ipilimumab for the treatment of multiple solid tumors in a multicohort trial. We show 54 historical shares outstanding datapoints in our IDRA shares outstanding history coverage, used to compute IDRA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IDRA market cap history over the course of time is important for investors interested in comparing IDRA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IDRA versus a peer is one thing; comparing IDRA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IDRA can fluctuate over the course of history. With this page we aim to empower investors researching IDRA by allowing them to research the IDRA market cap history. |
IDRA Current Stock Quote |
Free IDRA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
IDRA Share Performance |
Market Cap Peers |
Idera Pharmaceuticals (IDRA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
IDXG Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.